Title : Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy.

Pub. Date : 2010 Aug 15

PMID : 20564078






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. Imatinib Mesylate TNF superfamily member 10 Homo sapiens
2 Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. Imatinib Mesylate TNF superfamily member 10 Homo sapiens
3 RESULTS: Imatinib mesylate induced a significant TRAIL proapoptotic effect in EWS cells in vitro. Imatinib Mesylate TNF superfamily member 10 Homo sapiens